Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24422 | 261 | 28.9 | 37% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1647 | 6393 | WALL SHEAR STRESS//SHEAR STRESS//CAROTID BIFURCATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ARTERIOLOSCLEROSIS | Author keyword | 4 | 26% | 5% | 12 |
2 | NEPHROSCLEROSIS | Author keyword | 2 | 11% | 8% | 20 |
3 | DECOMPENSATED BENIGN NEPHROSCLEROSIS | Author keyword | 1 | 100% | 1% | 2 |
4 | GLOBAL GLOMERULOSCLEROSIS | Author keyword | 1 | 33% | 1% | 2 |
5 | ATHEROMA PRECURSORS | Author keyword | 1 | 50% | 0% | 1 |
6 | FED CONSUMER HLTH PROTECT VET MED | Address | 1 | 50% | 0% | 1 |
7 | HEART LUNG INNOVATST PAULS HOSP | Address | 1 | 50% | 0% | 1 |
8 | HYALINE SUBSTANCE | Author keyword | 1 | 50% | 0% | 1 |
9 | INVOLUTIONAL CHANGES | Author keyword | 1 | 50% | 0% | 1 |
10 | NON INDIGENOUS POPULATION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ATHERONECROSIS | 6 | 100% | 2% | 4 |
2 | NEPHROSCLEROSIS | 3 | 14% | 8% | 22 |
3 | BENIGN NEPHROSCLEROSIS | 2 | 36% | 2% | 4 |
4 | MALIGNANT NEPHROSCLEROSIS | 1 | 50% | 0% | 1 |
5 | FIBROPLASIA | 0 | 15% | 1% | 3 |
6 | EPIDEMIOLOGIC NECROPSY | 0 | 17% | 1% | 2 |
7 | ARTERIOLAR HYALINIZATION | 0 | 25% | 0% | 1 |
8 | SCLEROSING GLOMERULONEPHRITIS | 0 | 25% | 0% | 1 |
9 | HUMAN UTERINE ARTERIES | 0 | 13% | 0% | 1 |
10 | LIFESTYLE CHARACTERISTICS | 0 | 13% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
EARLY AND LATE MORPHOLOGIC CHANGES IN HUMAN CORONARY-ARTERIES AFTER PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY | 1983 | 37 | 12 | 42% |
Analysis of arterial intimal hyperplasia: review and hypothesis | 2007 | 14 | 196 | 4% |
Renal participation in cardiovascular risk in essential hypertension | 2001 | 3 | 27 | 7% |
POSTMORTEM CORONAROGRAPHY - CLINICO-MORPHOLOGICAL ASPECTS OF INTERPRETATION AND DIAGNOSTIC-VALUE | 1985 | 0 | 10 | 40% |
POSTMORTEM FINDINGS IN SUDDEN CARDIAC DEATH | 1989 | 7 | 47 | 9% |
DRUG-THERAPY OF ATHEROSCLEROSIS - CURRENT STATUS | 1990 | 1 | 57 | 7% |
INTIMAL THICKENING - A REVIEW AND A NEW HISTOGENETIC CONCEPT | 1983 | 0 | 30 | 23% |
COMPUTERIZED CARDIOVASCULAR IMAGING | 1983 | 1 | 17 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FED CONSUMER HLTH PROTECT VET MED | 1 | 50% | 0.4% | 1 |
2 | HEART LUNG INNOVATST PAULS HOSP | 1 | 50% | 0.4% | 1 |
3 | NOVARTIS FOR STIFTUNG | 1 | 50% | 0.4% | 1 |
4 | ABT PADIAT KARDIOL INTENS MED | 0 | 33% | 0.4% | 1 |
5 | SECC HISTOPATOL | 0 | 20% | 0.4% | 1 |
6 | DEV HUMAN NUTR HLTH | 0 | 17% | 0.4% | 1 |
7 | YAKUTSK SCI | 0 | 17% | 0.4% | 1 |
8 | ADJUNCT INTERNAL MED | 0 | 100% | 0.4% | 1 |
9 | HEART LUNG HLTHPROVIDENCE HLTH CARE INS | 0 | 100% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000191895 | AGE RELATED DECREASE IN PGI2 PRODUCTION//EN FACE TECHNIQUE//15 ISOPROSTANE F 2T |
2 | 0.0000140218 | HEART WEIGHT//NORMAL ORGAN WEIGHT//CARDIAC WEIGHT |
3 | 0.0000123263 | LINO ROSSI STUDY PREVENT UNEXPECTED PER//LINO ROSSI//SIUD |
4 | 0.0000109417 | FIBROUS PLAQUES//CHOLESTEROL SCREENING//PREVENT SECT |
5 | 0.0000086530 | MICROBIAL DIS PREVENT MED//TEACHING HOSP PATHOL//NEPALESE |
6 | 0.0000081781 | ELASTIC TISSUE TEARS//BIOENGINEERING FATIGUE//MURAL ATROPHY |
7 | 0.0000080753 | DIABET CELL BIOL//CELL BIOL DIABET//LOW DENSITY LIPOPROTEIN RETENTION |
8 | 0.0000074188 | IBUDILAST//CAS 50847 11 5//221 MIYAMA |
9 | 0.0000068055 | EXERCISE TL 201 TOMOGRAPHY//NEUROLEPTIC CARDIOMYOPATHY//CARDIOMYOPATHY ISCHEMIC |
10 | 0.0000067786 | INTRAVASCULAR ULTRASOUND//VIRTUAL HISTOLOGY//VULNERABLE PLAQUE |